Suchergebnisse - "Yunokawa, Mayu"

PubPharm (243)

1

Author's reply to : Revisiting the meaning of Trousseau sign and syndrome

enthalten in: Journal of gynecologic oncology | 2024

von Kanno, M. | Yunokawa, M. | Fusegi, A. | +3

2

Ovarian surveillance including endometrial cytology for patients with hereditary breast and ovarian cancer before risk-reducing salpingo-oophorectomy : A retrospective analysis

enthalten in: The journal of obstetrics and gynaecology research | 2024

von Fusegi, A. | Nomura, H. | Ueki, A. | +7

3

Risk-reducing decisions regarding germline BRCA pathogenic variant : focusing on the timing of genetic testing and RRSO

enthalten in: Journal of medical genetics | 2024

von Abe, A. | Nomura, H. | Fusegi, A. | +9

4

Analysis of East Asia subgroup in Study 309/KEYNOTE-775 : lenvatinib plus pembrolizumab versus treatment of physician's choice chemotherapy in patients with previously treated advanced or recurrent endometrial cancer

enthalten in: Journal of gynecologic oncology | 2024

von Yonemori, K. | Fujiwara, K. | Hasegawa, K. | +17

5

A survey of carboplatin desensitization therapy in Japan : A multicenter retrospective study

enthalten in: Cancer medicine | 2024

von Komatsu, H. | Matsumoto, K. | Morita, M. | +17

6

A first-in-human phase I study of TAS-117, an allosteric AKT inhibitor, in patients with advanced solid tumors

enthalten in: Cancer chemotherapy and pharmacology | 2024

von Doi, T. | Takahashi, S. | Aoki, D. | +11

7

Assessment of Pazopanib-Related Heart Failure in Patients With Advanced Soft Tissue Sarcoma　- A Single Institute Analysis

enthalten in: Circulation journal : official journal of the Japanese Circulation Society | 2024

von Wang, X. | Nakano, K. | Shiga, T. | +11

8

Ofranergene Obadenovec (Ofra-Vec, VB-111) With Weekly Paclitaxel for Platinum-Resistant Ovarian Cancer : Randomized Controlled Phase III Trial (OVAL Study/GOG 3018)

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Arend, R. | Monk, B. | Shapira-Frommer, R. | +89

9

Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc) : a randomised, open-label, phase 3 trial

enthalten in: Lancet (London, England) | 2024

von Oaknin, A. | Gladieff, L. | Martínez-García, J. | +117

10

Cerebral infarction caused by Trousseau syndrome associated with cervical cancer

enthalten in: Journal of gynecologic oncology | 2024

von Kanno, M. | Yunokawa, M. | Fusegi, A. | +3

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[25]